Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)

Clinical trial NCT02750345 · COMPLETED

Trial details

NCT number: NCT02750345
Sponsor: Cycle Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Tyrosinemia, Type I

Start date: 2016-03-01
Primary completion: 2016-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.